HOPE study impact on ACE inhibitors useHEMELS, Michiel E. H; BENNETT, Heather A; BONARI, Lori et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 640-645, issn 1060-0280, 6 p.Article

Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS)FARSANG, Csaba; LENGYEL, Maria; BORBAS, Sarolta et al.Current medical research and opinion. 2003, Vol 19, Num 3, pp 205-217, issn 0300-7995, 13 p.Article

Constructing a database of individual clinical trials for longitudinal analysisSCHMID, Christopher H; LANDA, Marcia; JAFAR, Tazeen H et al.Controlled clinical trials. 2003, Vol 24, Num 3, pp 324-340, issn 0197-2456, 17 p.Article

Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanismKOJI, Takafumi; ONISHI, Katsuya; DOHI, Kaoru et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 4, pp 632-639, issn 0160-2446, 8 p.Article

Effects of ACE inhibition on Myocardial apoptosis in an ischemia-reperfusion rat heart modelKOBARA, Miyuki; TATSUMI, Tetssya; NAKAGAWA, Masao et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 880-889, issn 0160-2446, 10 p.Article

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathyGROSS, M.-L; EL-SHAKMAK, A; SZABO, A et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 856-868, issn 0012-186X, 13 p.Article

Novel angiotensin I-converting enzyme inhibitory peptides derived from edible mushroom Agaricus bisporus (J.E. Lange) Imbach identified by LC-MS/MSCHING CHING LAU; ABDULLAH, Noorlidah; ADAWIYAH SURIZA SHUIB et al.Food chemistry. 2014, Vol 148, pp 396-401, issn 0308-8146, 6 p.Article

Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failureKAMBARA, Atsushi; CROSS, Bethany J; WUNG, Peter et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 830-837, issn 0160-2446, 8 p.Article

Analyse du consensus d'experts sur les inhibiteurs de l'enzyme de conversionAMARA, W.La Lettre du cardiologue. 2004, Num DEC, pp 5-7, issn 0761-5035, 3 p., NSConference Paper

Insertion/deletion polymorphism of the ACE gene and adherence to ACE inhibitorsSCHELLEMAN, H; KLUNGEL, O. H; VAN DUIJN, C. M et al.British journal of clinical pharmacology. 2005, Vol 59, Num 4, pp 483-485, issn 0306-5251, 3 p.Article

Misdiagnosis and mistreatment of a common side-effect: angiotensin-converting enzyme inhibitor-induced coughVEGTER, Stefan; DE LONG-VAN DEN BERG, Lolkje T. W.British journal of clinical pharmacology. 2010, Vol 69, Num 2, pp 200-203, issn 0306-5251, 4 p.Article

Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly ChineseLYNN, H; KWOK, T; WONG, S. Y. S et al.Bone (New York, NY). 2006, Vol 38, Num 4, pp 584-588, issn 8756-3282, 5 p.Article

Treatment with angiotensin-converting enzyme inhibitors : insight into perindopril cardiovascular protectionFERRARI, Roberto.European heart journal supplements. 2008, Vol 10, Num G, issn 1520-765X, G13-G20Conference Paper

Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in IrelandWAN D ADNAN, Wan A. H; ZAHARAN, Nur L; BENNETT, Kathleen et al.British journal of clinical pharmacology. 2011, Vol 71, Num 3, pp 458-466, issn 0306-5251, 9 p.Article

Analysis of Recurrent Angiotensin Converting Enzyme Inhibitor-Induced AngioedemaROBERTS, Daniel S; MAHONEY, Elizabeth J; HUTCHINSON, Christoph T et al.The Laryngoscope. 2008, Vol 118, Num 12, pp 2115-2120, issn 0023-852X, 6 p.Article

The clinical use of angiotensin-converting enzyme inhibitorsWONG, Joseph; PATEL, Rajiv A; KOWEY, Peter R et al.Progress in cardiovascular diseases. 2004, Vol 47, Num 2, pp 116-130, issn 0033-0620, 15 p.Article

In vivo endothelial interaction between ACE and COX inhibitorsGRYGLEWSKI, R. J; CHLOPICKI, S; SWIES, J et al.Prostaglandins, leukotrienes and essential fatty acids. 2005, Vol 72, Num 2, pp 129-131, issn 0952-3278, 3 p.Conference Paper

Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities)KAM SANG WOO; NORRIS, R. M; NICHOLLS, G et al.The American journal of cardiology. 1995, Vol 75, Num 14, pp 967-968, issn 0002-9149Article

The microbial modification of A58365A, an angiotensin converting enzyme inhibitorMYNDERSE, J. S; FUKUDA, D. S; HUNT, A. H et al.Journal of antibiotics (Tokyo. 1968). 1995, Vol 48, Num 5, pp 425-427, issn 0021-8820Article

Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonistsKYRMIZAKIS, Dionysios E; PAPADAKIS, Chariton E; LIOLIOS, Antonios D et al.Archives of otolaryngology, head & neck surgery. 2004, Vol 130, Num 12, pp 1416-1419, issn 0886-4470, 4 p.Article

Sulfur-Containing Angiotensin-Converting Enzyme Inhibitor 3-Thienylalanine-Ornithyl-Proline Activates Endothelial Function and Expression of Genes Involved in Renin―Angiotensin SystemCHAUDHARY, Snehlata; MAHESH KUMAR SETH; ISHWAR DUTT VATS et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 4, pp 311-317, issn 0160-2446, 7 p.Article

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials : NEW ASPECTS OF THE RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM (RAAS) IN CARDIOVASCULAR DISEASEVON LUEDER, Thomas G; KRUM, Henry.Cardiovascular drugs and therapy. 2013, Vol 27, Num 2, pp 171-179, issn 0920-3206, 9 p.Article

Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation : Treatment of Atherosclerosis as an Inflammatory DiseaseDI RAIMONDO, D; TUTTOLOMONDO, A; BUTTA, C et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 28, pp 4385-4413, issn 1381-6128, 29 p.Article

Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patientsPASINI, Anna Fratta; GARBIN, Ulisse; NAVA, Maria Cristina et al.American journal of hypertension. 2007, Vol 20, Num 4, pp 443-450, issn 0895-7061, 8 p.Article

Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactorCHIANG, Wen-Dee; TSOU, May-June; TSAI, Zong-Yao et al.Food chemistry. 2006, Vol 98, Num 4, pp 725-732, issn 0308-8146, 8 p.Article